These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34493353)

  • 1. Metabolic syndrome in antipsychotic-naïve patients with first-episode psychosis: a systematic review and meta-analysis.
    Garrido-Torres N; Rocha-Gonzalez I; Alameda L; Rodriguez-Gangoso A; Vilches A; Canal-Rivero M; Crespo-Facorro B; Ruiz-Veguilla M
    Psychol Med; 2021 Oct; 51(14):2307-2320. PubMed ID: 34493353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort.
    Garrido-Torres N; Ruiz-Veguilla M; Olivé Mas J; Rodríguez Gangoso A; Canal-Rivero M; Juncal-Ruiz M; Gómez-Revuelta M; Ayesa-Arriola R; Crespo-Facorro B; Vázquez-Bourgon J
    Span J Psychiatry Ment Health; 2023; 16(3):175-183. PubMed ID: 38520081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: Baseline results from the PAFIP cohort.
    Garrido-Torres N; Ruiz-Veguilla M; Alameda L; Canal-Rivero M; Ruiz MJ; Gómez-Revuelta M; Ayesa-Arriola R; Rubio-García A; Crespo-Facorro B; Vázquez-Bourgon J
    Schizophr Res; 2022 Aug; 246():277-285. PubMed ID: 35878542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Function and Variability in Antipsychotic Drug-Naive Patients With First-Episode Psychosis: A Systematic Review and Meta-Analysis.
    Lee M; Cernvall M; Borg J; Plavén-Sigray P; Larsson C; Erhardt S; Sellgren CM; Fatouros-Bergman H; Cervenka S
    JAMA Psychiatry; 2024 May; 81(5):468-476. PubMed ID: 38416480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic treatment is associated with inflammatory and metabolic biomarkers alterations among first-episode psychosis patients: A 7-month follow-up study.
    Balõtšev R; Haring L; Koido K; Leping V; Kriisa K; Zilmer M; Vasar V; Piir A; Lang A; Vasar E
    Early Interv Psychiatry; 2019 Feb; 13(1):101-109. PubMed ID: 28719155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis.
    Aymerich C; Pedruzo B; Pacho M; Laborda M; Herrero J; Pillinger T; McCutcheon RA; Alonso-Alconada D; Bordenave M; Martínez-Querol M; Arnaiz A; Labad J; Fusar-Poli P; González-Torres MÁ; Catalan A
    Psychoneuroendocrinology; 2023 Apr; 150():106049. PubMed ID: 36758330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first-episode psychosis (the STAGES study).
    O'Donoghue B; Allott K; Harrigan S; Scalzo F; Ward J; Mallawaarachchi S; Whitson S; Baldwin L; Graham J; Mullen E; MacNeil C; Alexander D; Wood SJ; Berk M; Alvarez-Jimenez M; Thompson A; Fornito A; Yuen HP; Nelson B; Francey SM; McGorry P
    Early Interv Psychiatry; 2023 Jun; 17(6):597-607. PubMed ID: 36196478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
    Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E
    Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis.
    Goff DC; Zeng B; Ardekani BA; Diminich ED; Tang Y; Fan X; Galatzer-Levy I; Li C; Troxel AB; Wang J
    JAMA Psychiatry; 2018 Apr; 75(4):370-378. PubMed ID: 29466532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis.
    Alvarez-Jiménez M; Parker AG; Hetrick SE; McGorry PD; Gleeson JF
    Schizophr Bull; 2011 May; 37(3):619-30. PubMed ID: 19900962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging biological markers in a cohort of antipsychotic-naïve first-episode psychosis patients.
    Talarico F; Xavier G; Ota VK; Spindola LM; Maurya PK; Tempaku PF; Moretti PS; Gadelha A; Noto M; Noto C; Cordeiro Q; Bressan RA; de Jong S; Santoro ML; Breen G; Belangero SI
    Psychoneuroendocrinology; 2021 Oct; 132():105350. PubMed ID: 34271521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures.
    Lee J; Xue X; Au E; McIntyre WB; Asgariroozbehani R; Panganiban K; Tseng GC; Papoulias M; Smith E; Monteiro J; Shah D; Maksyutynska K; Cavalier S; Radoncic E; Prasad F; Agarwal SM; Mccullumsmith R; Freyberg Z; Logan RW; Hahn MK
    Transl Psychiatry; 2024 Jan; 14(1):19. PubMed ID: 38199991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis.
    Noto C; Ota VK; Gouvea ES; Rizzo LB; Spindola LM; Honda PH; Cordeiro Q; Belangero SI; Bressan RA; Gadelha A; Maes M; Brietzke E
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment for psychotic depression.
    Wijkstra J; Lijmer J; Burger H; Cipriani A; Geddes J; Nolen WA
    Cochrane Database Syst Rev; 2015 Jul; (7):CD004044. PubMed ID: 26225902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment for psychotic depression.
    Wijkstra J; Lijmer J; Burger H; Geddes J; Nolen WA
    Cochrane Database Syst Rev; 2013 Nov; (11):CD004044. PubMed ID: 24282034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis use and nonuse in patients with first-episode psychosis: A systematic review and meta-analysis of studies comparing neurocognitive functioning.
    Sánchez-Gutiérrez T; Fernandez-Castilla B; Barbeito S; González-Pinto A; Becerra-García JA; Calvo A
    Eur Psychiatry; 2020 Jan; 63(1):e6. PubMed ID: 32093788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
    Rawat VS; Ganesh S; Bijjal S; Shanivaram Reddy K; Agarwal V; Devi R; Kumar CN; Christopher R; Thirthalli J
    Schizophr Res; 2018 Feb; 192():102-107. PubMed ID: 28454923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.
    Jensen KG; Correll CU; Rudå D; Klauber DG; Stentebjerg-Olesen M; Fagerlund B; Jepsen JRM; Fink-Jensen A; Pagsberg AK
    J Clin Psychiatry; 2017; 78(8):e1035-e1046. PubMed ID: 28102978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis.
    Foley DL; Morley KI
    Arch Gen Psychiatry; 2011 Jun; 68(6):609-16. PubMed ID: 21300937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical Trial.
    Chopra S; Francey SM; O'Donoghue B; Sabaroedin K; Arnatkeviciute A; Cropley V; Nelson B; Graham J; Baldwin L; Tahtalian S; Yuen HP; Allott K; Alvarez-Jimenez M; Harrigan S; Pantelis C; Wood SJ; McGorry P; Fornito A
    JAMA Psychiatry; 2021 Sep; 78(9):994-1004. PubMed ID: 34160595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.